AC
NVAX icon

AXQ Capital’s Novavax NVAX Stock Holding History

AXQ Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$456K Buy
55,989
+26,022
+87% +$236K 0.06% 442
2025
Q4 		$201K Sell
29,967
-21,294
-42% -$161K 0.05% 570
2025
Q3 		$444K Buy
+51,261
New +$399K 0.17% 215
2025
Q2 		– Sell
-13,831
Closed -$88.7K – 714
2025
Q1 		$88.7K Buy
+13,831
New +$114K 0.04% 447
2023
Q3 		– Sell
-17,800
Closed -$132K – 560
2023
Q2 		$132K Buy
17,800
+3,814
+27% +$30K 0.16% 225
2023
Q1 		$96.9K Buy
+13,986
New +$129K 0.04% 446

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AXQ Capital's NVAX Position: Q1 2026 in Review

AXQ Capital increased its Novavax (NVAX) stake by 87% in Q1 2026, buying an estimated $236K and bringing the position to 55,989 shares worth $456K. The position accounts for 0.06% of the portfolio, ranked #442.

AXQ Capital first reported a position in NVAX in Q1 2023 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • AXQ Capital held 55,989 shares of Novavax worth $456K as of Q1 2026.
  • AXQ Capital bought 26,022 Novavax shares in Q1 2026, an estimated $236K.
  • Novavax made up 0.06% of AXQ Capital's portfolio in Q1 2026, its #442 holding.
  • AXQ Capital first reported a position in Novavax in Q1 2023 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.